These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 22778556)
1. Identification of HLA-A24-restricted novel T Cell epitope peptides derived from P-cadherin and kinesin family member 20A. Osawa R; Tsunoda T; Yoshimura S; Watanabe T; Miyazawa M; Tani M; Takeda K; Nakagawa H; Nakamura Y; Yamaue H J Biomed Biotechnol; 2012; 2012():848042. PubMed ID: 22778556 [TBL] [Abstract][Full Text] [Related]
2. Identification of promiscuous KIF20A long peptides bearing both CD4+ and CD8+ T-cell epitopes: KIF20A-specific CD4+ T-cell immunity in patients with malignant tumor. Tomita Y; Yuno A; Tsukamoto H; Senju S; Kuroda Y; Hirayama M; Irie A; Kawahara K; Yatsuda J; Hamada A; Jono H; Yoshida K; Tsunoda T; Kohrogi H; Yoshitake Y; Nakamura Y; Shinohara M; Nishimura Y Clin Cancer Res; 2013 Aug; 19(16):4508-20. PubMed ID: 23714729 [TBL] [Abstract][Full Text] [Related]
3. Identification of human leukocyte antigen-A24-restricted epitope peptides derived from gene products upregulated in lung and esophageal cancers as novel targets for immunotherapy. Suda T; Tsunoda T; Daigo Y; Nakamura Y; Tahara H Cancer Sci; 2007 Nov; 98(11):1803-8. PubMed ID: 17784873 [TBL] [Abstract][Full Text] [Related]
4. Identification of novel MAGE-A6- and MAGE-A12-derived HLA-A24-restricted cytotoxic T lymphocyte epitopes using an in silico peptide-docking assay. Akiyama Y; Komiyama M; Nakamura Y; Iizuka A; Oshita C; Kume A; Nogami M; Miyata H; Ashizawa T; Yoshikawa S; Kiyohara Y; Yamaguchi K Cancer Immunol Immunother; 2012 Dec; 61(12):2311-9. PubMed ID: 22707303 [TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of HLA-A24-specific XBP1, CD138 (Syndecan-1) and CS1 (SLAMF7) peptides inducing antigens-specific memory cytotoxic T lymphocytes targeting multiple myeloma. Bae J; Hideshima T; Zhang GL; Zhou J; Keskin DB; Munshi NC; Anderson KC Leukemia; 2018 Mar; 32(3):752-764. PubMed ID: 29089645 [TBL] [Abstract][Full Text] [Related]
6. Identification of HLA-A*0201/-A*2402-restricted CTL epitope-peptides derived from a novel cancer/testis antigen, MCAK, and induction of a specific antitumor immune response. Kawamoto M; Tanaka F; Mimori K; Inoue H; Kamohara Y; Mori M Oncol Rep; 2011 Feb; 25(2):469-76. PubMed ID: 21165574 [TBL] [Abstract][Full Text] [Related]
7. Screening of HLA-A24-restricted epitope peptides from prostate-specific membrane antigen that induce specific antitumor cytotoxic T lymphocytes. Horiguchi Y; Nukaya I; Okazawa K; Kawashima I; Fikes J; Sette A; Tachibana M; Takesako K; Murai M Clin Cancer Res; 2002 Dec; 8(12):3885-92. PubMed ID: 12473604 [TBL] [Abstract][Full Text] [Related]
8. Identification of HLA-A24-restricted CD8(+) cytotoxic T-cell epitopes derived from mammaglobin-A, a human breast cancer-associated antigen. Tiriveedhi V; Sarma NJ; Subramanian V; Fleming TP; Gillanders WE; Mohanakumar T Hum Immunol; 2012 Jan; 73(1):11-6. PubMed ID: 22074997 [TBL] [Abstract][Full Text] [Related]
9. Identification of HLA-A24-restricted CTL epitope from cancer-testis antigen, NY-ESO-1, and induction of a specific antitumor immune response. Yamaguchi H; Tanaka F; Ohta M; Inoue H; Mori M Clin Cancer Res; 2004 Feb; 10(3):890-6. PubMed ID: 14871964 [TBL] [Abstract][Full Text] [Related]
10. A newly identified MAGE-3-derived, HLA-A24-restricted peptide is naturally processed and presented as a CTL epitope on MAGE-3-expressing gastrointestinal cancer cells. Miyagawa N; Kono K; Mimura K; Omata H; Sugai H; Fujii H Oncology; 2006; 70(1):54-62. PubMed ID: 16446550 [TBL] [Abstract][Full Text] [Related]
11. Identification of novel human leukocyte antigen-A*11:01-restricted cytotoxic T-lymphocyte epitopes derived from osteosarcoma antigen papillomavirus binding factor. Li D; Toji S; Watanabe K; Torigoe T; Tsukahara T Cancer Sci; 2019 Apr; 110(4):1156-1168. PubMed ID: 30767336 [TBL] [Abstract][Full Text] [Related]
12. Identification of HLA-A2-restricted CTL epitopes of a novel tumour-associated antigen, KIF20A, overexpressed in pancreatic cancer. Imai K; Hirata S; Irie A; Senju S; Ikuta Y; Yokomine K; Harao M; Inoue M; Tomita Y; Tsunoda T; Nakagawa H; Nakamura Y; Baba H; Nishimura Y Br J Cancer; 2011 Jan; 104(2):300-7. PubMed ID: 21179034 [TBL] [Abstract][Full Text] [Related]
13. Phase I/II clinical trial using HLA-A24-restricted peptide vaccine derived from KIF20A for patients with advanced pancreatic cancer. Asahara S; Takeda K; Yamao K; Maguchi H; Yamaue H J Transl Med; 2013 Nov; 11():291. PubMed ID: 24237633 [TBL] [Abstract][Full Text] [Related]
14. Comparative study on the immunogenicity between an HLA-A24-restricted cytotoxic T-cell epitope derived from survivin and that from its splice variant survivin-2B in oral cancer patients. Kobayashi J; Torigoe T; Hirohashi Y; Idenoue S; Miyazaki A; Yamaguchi A; Hiratsuka H; Sato N J Transl Med; 2009 Jan; 7():1. PubMed ID: 19123955 [TBL] [Abstract][Full Text] [Related]
15. A newly identified MAGE-3-derived epitope recognized by HLA-A24-restricted cytotoxic T lymphocytes. Oiso M; Eura M; Katsura F; Takiguchi M; Sobao Y; Masuyama K; Nakashima M; Itoh K; Ishikawa T Int J Cancer; 1999 May; 81(3):387-94. PubMed ID: 10209953 [TBL] [Abstract][Full Text] [Related]
16. Kinesin superfamily protein-derived peptides with the ability to induce glioma-reactive cytotoxic T lymphocytes in human leukocyte antigen-A24+ glioma patients. Harada M; Ishihara Y; Itoh K; Yamanaka R Oncol Rep; 2007 Mar; 17(3):629-36. PubMed ID: 17273744 [TBL] [Abstract][Full Text] [Related]
17. Identification of HLA-A24-restricted CTL epitope encoded by the matrix protein pp65 of human cytomegalovirus. Akiyama Y; Maruyama K; Mochizuki T; Sasaki K; Takaue Y; Yamaguchi K Immunol Lett; 2002 Aug; 83(1):21-30. PubMed ID: 12057851 [TBL] [Abstract][Full Text] [Related]
18. Characterization of an human leucocyte antigen A2-restricted Epstein-Barr virus nuclear antigen-1-derived cytotoxic T-lymphocyte epitope. Marescotti D; Destro F; Baldisserotto A; Marastoni M; Coppotelli G; Masucci M; Gavioli R Immunology; 2010 Mar; 129(3):386-95. PubMed ID: 19922423 [TBL] [Abstract][Full Text] [Related]
19. Weak binder for MHC molecule is a potent Mycobacterium tuberculosis-specific CTL epitope in the context of HLA-A24 allele. Wang Y; Sun M; He M; Cui H; Zhang J; Shi L; Wang W; Xu W; Gao B; Ding J Microb Pathog; 2012 Sep; 53(3-4):162-7. PubMed ID: 22819798 [TBL] [Abstract][Full Text] [Related]
20. An HLA-A24-restricted cytotoxic T lymphocyte epitope of a tumor-associated protein, survivin. Hirohashi Y; Torigoe T; Maeda A; Nabeta Y; Kamiguchi K; Sato T; Yoda J; Ikeda H; Hirata K; Yamanaka N; Sato N Clin Cancer Res; 2002 Jun; 8(6):1731-9. PubMed ID: 12060610 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]